{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Newborn&page=6", "query": { "condition": "Newborn", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 11249, "total_pages": 1125, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Newborn&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Newborn&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-02T20:02:16.467Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05018130", "title": "Bio-Integrative Versus Metallic Screws for Calcaneus Osteotomies", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Flatfoot", "Bone Resorption", "Cavus Deformity", "Osteolysis", "Complication" ], "interventions": [ { "name": "Calcaneus Osteotomy (Metallic)", "type": "PROCEDURE" }, { "name": "Calcaneus Osteotomy (Bio-integrative)", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Iowa", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 44, "start_date": "2021-11-01", "completion_date": "2024-12-01", "has_results": false, "last_update_posted_date": "2023-09-06", "last_synced_at": "2026-11-02T20:02:16.467Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT05018130" }, { "nct_id": "NCT00128492", "title": "Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "AZLI 75 mg two times a day (BID)/ three times a day (TID)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 274, "start_date": "2005-08", "completion_date": "2009-01", "has_results": true, "last_update_posted_date": "2011-05-19", "last_synced_at": "2026-11-02T20:02:16.467Z", "location_count": 56, "location_summary": "Birmingham, Alabama • Anchorage, Alaska • Phoenix, Arizona + 53 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00128492" }, { "nct_id": "NCT02926092", "title": "Observational Natural History Study of Autosomal Dominant Retinitis Pigmentosa (adRP)", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Retinitis Pigmentosa" ], "interventions": [ { "name": "Observation", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1, "start_date": "2017-03-13", "completion_date": "2017-04-13", "has_results": false, "last_update_posted_date": "2021-03-17", "last_synced_at": "2026-11-02T20:02:16.467Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02926092" }, { "nct_id": "NCT07778836", "title": "A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Friedreich Ataxia", "Friedreich's Ataxia" ], "interventions": [ { "name": "Nomlabofusp", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Larimar Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "12 Years to 40 Years" }, "enrollment_count": 150, "start_date": "2026-10-26", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-11-02T20:02:16.467Z", "location_count": 4, "location_summary": "Tampa, Florida • Chicago, Illinois • Eatontown, New Jersey + 1 more", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Eatontown", "state": "New Jersey" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07778836" }, { "nct_id": "NCT01506544", "title": "Pharmacokinetics (PK) of Liquid Hydroxyurea in Pediatric Patients With Sickle Cell Anemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Sickle Cell Anemia" ], "interventions": [ { "name": "Hydroxyurea", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Mercy Hospital Kansas City", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 39, "start_date": "2011-12", "completion_date": "2014-01", "has_results": false, "last_update_posted_date": "2014-12-12", "last_synced_at": "2026-11-02T20:02:16.467Z", "location_count": 6, "location_summary": "Birmingham, Alabama • Chicago, Illinois • New York, New York + 3 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New York", "state": "New York" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01506544" }, { "nct_id": "NCT03219164", "title": "Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pseudomonas Aeruginosa Respiratory Tract Infection/Colonization", "Cystic Fibrosis" ], "interventions": [ { "name": "AZLI", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "3 Months to 18 Years" }, "enrollment_count": 149, "start_date": "2017-11-28", "completion_date": "2021-09-23", "has_results": true, "last_update_posted_date": "2022-06-14", "last_synced_at": "2026-11-02T20:02:16.467Z", "location_count": 12, "location_summary": "San Francisco, California • Washington D.C., District of Columbia • St. Petersburg, Florida + 8 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "St. Petersburg", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03219164" }, { "nct_id": "NCT05285839", "title": "Dupixent and Narrowband UVB for Atopic Dermatitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Dupixent", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Psoriasis Treatment Center of Central New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2022-04-19", "completion_date": "2024-12-15", "has_results": false, "last_update_posted_date": "2024-03-15", "last_synced_at": "2026-11-02T20:02:16.467Z", "location_count": 1, "location_summary": "East Windsor, New Jersey", "locations": [ { "city": "East Windsor", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05285839" }, { "nct_id": "NCT05193981", "title": "A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Autosomal Dominant Polycystic Kidney Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "15 Years to 40 Years" }, "enrollment_count": 80, "start_date": "2021-09-14", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-04-16", "last_synced_at": "2026-11-02T20:02:16.467Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05193981" }, { "nct_id": "NCT02989571", "title": "The Effects of Increased IV Hydration on Nulliparous Women Undergoing an Induction of Labor", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Labor; Forced or Induced, Affecting Fetus or Newborn" ], "interventions": [ { "name": "Intravenous normal saline administered at 250ml/hr", "type": "DRUG" }, { "name": "Intravenous normal saline administered at 125ml/hr", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MemorialCare Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 180, "start_date": "2016-03", "completion_date": "2020-12", "has_results": false, "last_update_posted_date": "2023-01-20", "last_synced_at": "2026-11-02T20:02:16.467Z", "location_count": 1, "location_summary": "Long Beach, California", "locations": [ { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02989571" }, { "nct_id": "NCT06003023", "title": "Congenital Heart Disease Physical Activity Lifestyle Study V.2", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Heart Defects, Congenital", "Cardiovascular Disease Other" ], "interventions": [ { "name": "Physical Activity Monitoring", "type": "BEHAVIORAL" }, { "name": "Tailored Exercise Prescription", "type": "BEHAVIORAL" }, { "name": "Healthy Lifestyle Education", "type": "BEHAVIORAL" }, { "name": "Physical Activity Lifestyle Intervention Informed by the Theory of Planned Behavior", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Jamie Jackson", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "15 Years to 25 Years" }, "enrollment_count": 144, "start_date": "2023-07-18", "completion_date": "2027-07-30", "has_results": false, "last_update_posted_date": "2026-06-01", "last_synced_at": "2026-11-02T20:02:16.467Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06003023" } ] }